These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 11849389

  • 1. Effects of human soluble thrombomodulin on experimental glomerulonephritis.
    Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato T, Natori Y, Akatsu H, Campbell W, Okada N, Okada H, Yuzawa Y, Matsuo S.
    Kidney Int; 2002 Feb; 61(2):490-501. PubMed ID: 11849389
    [Abstract] [Full Text] [Related]

  • 2. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats.
    Gonda Y, Hirata S, Saitoh K, Aoki Y, Mohri M, Gomi K, Sugihara T, Kiyota T, Yamamoto S, Ishida T.
    Thromb Res; 1993 Aug 15; 71(4):325-35. PubMed ID: 8236161
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure.
    Ozaki T, Anas C, Maruyama S, Yamamoto T, Yasuda K, Morita Y, Ito Y, Gotoh M, Yuzawa Y, Matsuo S.
    Nephrol Dial Transplant; 2008 Jan 15; 23(1):110-9. PubMed ID: 17804460
    [Abstract] [Full Text] [Related]

  • 5. Antithrombotic effects of recombinant human soluble thrombomodulin (rhs-TM) on arteriovenous shunt thrombosis in rats.
    Aoki Y, Takei R, Mohri M, Gonda Y, Gomi K, Sugihara T, Kiyota T, Yamamoto S, Ishida T, Maruyama I.
    Am J Hematol; 1994 Nov 15; 47(3):162-6. PubMed ID: 7942778
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation.
    Uchiba M, Okajima K, Murakami K, Johno M, Mohri M, Okabe H, Takatsuki K.
    Am J Physiol; 1997 Oct 15; 273(4):L889-94. PubMed ID: 9357866
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis.
    Campbell W, Okada N, Okada H.
    Immunol Rev; 2001 Apr 15; 180():162-7. PubMed ID: 11414358
    [Abstract] [Full Text] [Related]

  • 12. Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma.
    Mohri M, Suzuki M, Sugimoto E, Sata M, Yamamoto S, Maruyama I.
    Thromb Haemost; 1998 Dec 15; 80(6):925-9. PubMed ID: 9869162
    [Abstract] [Full Text] [Related]

  • 13. Induction of pulmonary thromboembolism by neutrophil elastase in collagen-induced arthritis mice and effect of recombinant human soluble thrombomodulin.
    Matsuoka T, Jin E, Tachihara A, Ghazizadeh M, Nakajima A, Yoshino S, Katayama Y, Kawanami O.
    Pathobiology; 2008 Dec 15; 75(5):295-305. PubMed ID: 18931532
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of a new synthetic selectin blocker in an acute rat thrombotic glomerulonephritis.
    Ito I, Yuzawa Y, Mizuno M, Nishikawa K, Tashita A, Jomori T, Hotta N, Matsuo S.
    Am J Kidney Dis; 2001 Aug 15; 38(2):265-73. PubMed ID: 11479151
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.